AVH 1.62% $3.03 avita medical inc.

Ann: FDA Approves Continued Access to ReCell in US Burns Trial-AVH.AX, page-4

  1. 2,013 Posts.
    lightbulb Created with Sketch. 118
    A big step toward what we are hinging our bet on here. FDA and US approvals timelines are getting closer with decisions like this; suggests mere formality. (OK we haven't approved you formally yet, but here's a temporary pass while you're waiting for i's and t's)
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.